CDE Detailed Report
Disease: cookie-policy
Sub-Domain: Outcomes and End Points
CRF:
Sub-Domain: Outcomes and End Points
CRF:
55 results.
CDE ID | CDE Name | Variable Name | Definition | Short Description | Additional Notes (Question Text) | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guideline) | Sub Domain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | Source | Form Set | Form | Field | Domain | CDASH Variable | CDASH Definition | CDASH Label | Controlled Terminology | Prompt | Essentiality | Question Text | CDASH imp guidance | SDTM IG target | csDSR | PhenX | Data Type | CRF Completion Inst | SDTMIG Target Var | SDTMIG Target Map | Codelist Name | PVs | Pre Pop Value | Query Display | List Style |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C60652 | On target indel frequency associate adverse outcome indicator | OnTgtIndlFrqAssocAdvOutcmInd | Indicator of whether the on-target indel frequency is associated with an adverse outcome. | Indicator of whether the on-target indel frequency is associated with an adverse outcome. | Is the on-target indel frequency associated with an adverse outcome? (e.g. thalassemia phenotype) | No;Yes | No;Yes | Alphanumeric | Adult;Pediatric | Core | 1.00 | 2021-04-30 12:02:06.0 | Gene Product Follow-Up | Outcomes and End Points | Genetics%2FAssays |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
C60631 | Elapsed time from infusion at visit category | ElapsTimFrmInfusAtVisitCat | Category of elapsed time since infusion as of the visit being documented. | Category of elapsed time since infusion as of the visit being documented. | VISIT [X] CRF (Time since Infusion): | Day 0;6 months;1 year;1.5 years;2 years;3 years;4 years;5 years;6 years;7 years;8 years;9 years;10 years;11 years;12 years;13 years;14 years;15 years | Day 0;6 months;1 year;1.5 years;2 years;3 years;4 years;5 years;6 years;7 years;8 years;9 years;10 years;11 years;12 years;13 years;14 years;15 years | Alphanumeric | Adult;Pediatric | Core | 1.00 | 2021-04-29 16:11:55.0 | Gene Product Follow-Up | Outcomes and End Points | Genetics%2FAssays |
Single Pre-Defined Value Selected |
|||||||||||||||||||||||||||||||
C60392 | Sample collect date | SamplCollectDate | Date on which a sample was collected. | Date on which a sample was collected. | Date sample drawn | Date or Date & Time | Adult;Pediatric | Core | 1.00 | 2021-01-15 16:40:21.0 | Gene Product Follow-Up | Outcomes and End Points | Genetics%2FAssays |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
C60491 | Integrating viral vector copy number bone marrow CD34 plus lineage value | IntgrtVrlVCNCD34PlsLneagVal | Value of the integrating viral vector copy number (VCN) in bone marrow for the CD34+ lineage. | Value of the integrating viral vector copy number (VCN) in bone marrow for the CD34+ lineage. | Bone Marrow VCN: CD34+ | Numeric Values | Adult;Pediatric | Core | 1.00 | 2021-04-22 13:25:18.0 | Gene Product Follow-Up | Outcomes and End Points | Genetics%2FAssays |
Free-Form Entry |
|||||||||||||||||||||||||||||||||
C60642 | Gene editing blood CD3 plus lineage off target indel count | GnEdBldCD3PlsLinOffTgtIndelCt | Count of gene-editing off-target indels in the blood CD3+ lineage. | Count of gene-editing off-target indels in the blood CD3+ lineage. | Off-target Indels in Specific Blood Lineages: CD3+ | Numeric Values | Adult | Core | 1.00 | 2021-04-23 11:20:12.0 | Gene Product Follow-Up | Outcomes and End Points | Genetics%2FAssays |
Free-Form Entry |
55 results.